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Purpose: To examine karyotype changes in cultured human corneal endothelial cells (HCECs).
Methods: HCECs with Descemet’s membrane were removed from 20 donors of various ages (range, 2–77 years; average,
43.7±26.4 years) and cultured on dishes coated with extracellular matrix produced by bovine corneal endothelial cells
(BCECs). Karyotype changes were examined by G-band karyotyping of HCECs at the third passage from 12 donors and
the fifth passage from 16 donors. The number of chromosomes was analyzed in 40–50 cells from the third and fifth
passages of each HCEC preparation. A detailed karyotype analysis of 10–16 cells from the third and fifth passages of each
HCEC preparation was performed. The frequency of aneuploid cells per case (the number of abnormal cells divided by
the total number of cells examined at metaphase) was tested for correlation with age by Spearman’s correlation analysis.
Results: At the third passage, five cases (41.7%) showed an almost normal karyotype, and five cases (41.7%) showed
sex chromosome loss. One case (8.3%) showed chromosome 21 trisomy. At the fifth passage, five cases (31.3%) showed
an  almost  normal  karyotype,  and  four  cases  (25%)  showed  sex  chromosome  loss.  Three  cases  (18.8%)  showed
chromosome 8 trisomy, and one case (6.3%) showed chromosome 21 trisomy. Donor age and the frequency of aneuploidy
had a statistically significant correlation at the fifth passage (R=0.653, p=0.042).
Conclusions: Donor age and the frequency of aneuploidy have a positive correlation in cultured HCECs at the fifth
passage. Therefore, HCECs for clinical therapies should be obtained from donors as young as possible. Karyotyping
cultured HCECs is crucial before clinical application.
Corneal  endothelial  dysfunction  is  caused  by  various
diseases and surgeries such as Fuchs’ endothelial dystrophy,
trauma,  cataract  surgery,  glaucoma  surgery,  and  laser
iridotomy and is a major cause of corneal transplantation.
Because  corneas  from  donors  are  in  grave  shortage
worldwide,  there  is  a  potentially  large  role  for  corneal
endothelial  tissue  bioengineering  in  treating  patients  with
endothelial  dysfunction.  Since  human  corneal  endothelial
cells (HCECs) can be grown in culture [1-7], the application
of  cultured  HCEC  transplantation  to  corneal  endothelial
dysfunction has been investigated [8-13]. However, cultured
cells tend to have a potential risk of karyotype changes [14,
15], which are often associated with carcinogenesis. Thus,
cultured HCECs should be carefully examined before clinical
application.  Moreover,  preparing  and  examining  cultured
HCECs on time for surgery could be difficult since the time
of the donor’s death cannot be predicted accurately before the
donor’s death. Cryopreservation of cultured HCECs provides
a solution for this problem if its safety can be proven. We
conducted  this  study  to  examine  karyotype  changes  in
cultured HCECs with or without cryopreservation.
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METHODS
Human  corneal  endothelial  cell  donors:  HCECs  were
obtained from 20 human cadaver corneas and were cultured
before  performing  karyotyping  analysis.  The  donor  age
ranged from 2 to 75 years (average 43.7±26.4). Nine males
and  11  females  were  included.  All  donor  corneas  were
preserved in Optisol GS (Bausch & Lomb, Rochester, NY)
and imported by airplane from the Rocky Mountain Lions Eye
Bank for research purposes. The donor information showed
that  all  donor  corneas  were  considered  healthy  without
corneal  disease  and  all  donors  had  no  past  history  of
chromosomal  abnormality.  The  demographic  data  of  the
donors are shown in Table 1. The confidentiality of donor
information was maintained according to the Declaration of
Helsinki.
Preparation of culture dishes: All culture dishes were coated
with  bovine  corneal  endothelial  extracellular  matrix
according to a previously reported method [7]. Bovine corneal
endothelial cells were cultured from young, locally obtained
calf eyes. Primary cultures of bovine corneal endothelial cells
(BCECs)  were  established  from  explants  of  the  corneal
endothelial cell layer in 60 mm culture dishes after which they
were  propagated  using  standard  techniques  in  a  medium
consisting of Dulbecco’s modified Eagle’s medium with 10%
fetal bovine serum, 5% calf serum, 30 mg/l of L-glutamine,
2.5 mg/l of fungizone, 2.5 mg/l of doxycycline, 2 ng/ml of
basic  fibroblast  growth  factor,  and  2%  dextran.  For
extracellular matrix (ECM) production, six confluent 100 mm
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942Figure 1. Examples of HCEC cultures. Cultured HCECs at primary
culture (A) and fifth passage (B). A: The donor age was five years old.
B: The donor age was 21 years old. Hexagonal confluent cells were
recognized in both cultures. A strip of Descemet’s membrane (arrow
in A) was observed in the primary culture. Bars=100 μm
dishes  of  BCECs  were  trypsinized  using  trypsin-EDTA
(0.05% trypsin and 0.53mM of EDTA) and then added to
500  ml  of  the  ECM  production  media.  Unless  otherwise
specified, the media were changed every two to three days for
HCEC and BCEC cultures. The cell suspension was added at
volumes appropriate for the culture dishes being prepared and
then was incubated until confluent without a media change.
Cells  were  then  lysed  for  5  min  in  a  0.14%  ammonium
hydroxide solution in distilled water. The plates were rinsed
three times in Ca2+-free and Mg2+-free phosphate buffered
saline. After having been scanned by microscope to confirm
complete removal of all the bovine corneal endothelial cells,
the dishes were stored at 4 °C in a sterile medium consisting
of Ca2+-free and Mg2+-free phosphate buffered saline with
2.5 mg/l of fungizone and 12.5 mg/l of doxycycline until use
in culture.
Human corneal endothelial cell culture: HCEC culture was
prepared as described in our previous report [7]. Primary
cultures were established from explants of the endothelial cell
layer with Descemet’s membrane from the peripheral part of
the cornea and were propagated on the culture dishes coated
with bovine corneal endothelial extracellular matrix. HCECs
were cultivated with Dulbecco’s modified Eagle’s medium
supplemented with 15% fetal bovine serum, 30 mg/l of L-
glutamine, 2.5 mg/l of fungizone (GIBCO BRL, Grand Island,
NY), 2.5 mg of doxycycline, and 2 ng/ml of basic fibroblast
growth factor. Cell lines were maintained in a humidified
incubator at 37 °C in 10% CO2. The media were changed every
TABLE 1. DEMOGRAPHIC DATA OF DONORS.
Donor# Age Gender Cause of death                                                 Ventilation
                               Death to 
                            preservation
time                               time
Death to
culture
1 3 F Medulloblastoma Yes (1 month) 5:59 9 days
2 12 M Anaplastic astrocytoma No 12:06 10 days
3 21 F Seizure disorder No 15:58 6 days
4 38 F Lymphangioleiomyomatosis Yes (1 month) 4:41 5 days
5 55 M Myocardial infarction No 7:23 11 days
6 60 F Colon cancer NA 3:10 2 days
7 61 M Pancreatic cancer No 7:15 8 days
8 73 F Chronic obstructive pulmonary disease No 4:49 6 days
9 18 M Trauma Yes (20 min) 13:12 7 days
10 57 M Myocardial infarction Yes (24 h) 4:35 8 days
11 70 M Myocardial infarction Yes (7 h) 5:34 6 days
12 77 M Cerebrovascular accident Yes (7 h) 3:36 8 days
13 2 M NA NA NA NA
14 4 F Congestive heart failure No 9:10 7 days
15 20 F NA NA NA NA
16 45 F Colon cancer NA 2:00 5 days
17 57 F GI bleed No 3:43 7 days
18 58 M Renal disease No 5:00 5 days
19 68 F Bowel cancer Yes (20 days) 6:16 6 days
20 75 F Renal failure No 5:29 8 days
The table has been arranged according to donor age in three subgroups as follows: #1–8, the examination was conducted at both
passages 3 and 5; #9–12, the examination was conducted at passage 3 only; and #13–20, the examination was conducted at
passage 5 only. Death to preservation time is expressed in hours and minutes. “NA” denotes that data were not available.
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943two  or  three  days.  After  confirming  adequate  density  of
proliferating  cells  after  about  10–20  days,  passaging
procedure was performed. HCECs were rinsed three times in
Ca2+-free  and  Mg2+-free  phosphate  buffered  saline,
trypsinized for 2 min at 37 °C, and passaged at ratios of 1:4.
All  subsequent  passaging  was  performed  using  the  same
method after HCECs in the dishes became confluent. The
approximate time to confluence after each passaging was six
to eight days.
Cryopreservation:  Several  cell  lines  were  processed  for
cryopreservation.  Third  passage  HCECs  were  frozen  by
mixing them with a cell freezing solution (Cell Banker®; Juji
Field Inc, Tokyo, Japan) and preserved at −152 °C. The frozen
HCECs were defrosted in a 37 °C homeothermal tank. After
adding 10 ml of culturing solution, defrosted HCECs were
centrifuged and plated into dishes.
Karyotyping: Cytogenetic examination was performed at the
third passage from 12 donors and at the fifth passage from 16
donors.  In  eight  donors,  cytogenetic  examination  was
performed at both the third and fifth passages. In the early
stage of this study, cytogenetic examination was performed
only at the fifth passage. Moreover, HCECs from several
donors could be cultured to the third passage but not to the
fifth passage. These are the reasons why there are unequal
sample  sizes  for  the  third  and  fifth  passages.  Standard
cytogenetic harvesting, fixation, and G-bands after trypsin
and Giemsa (GTG banding) techniques were used for HCECs.
After incubation with 0.06 μg/ml colcemid for 16 h to arrest
cell  mitosis,  HCECs  were  detached  using  0.05%  trypsin/
EDTA. HCECs were treated with 0.075 M KCl and then
fixated with Carnoy’s fixative (a 3:1 mixture of methanol and
glacial acetic). HCEC solution was dropped onto a slide glass
and air-dried. Then, HCECs were treated with 0.005% trypsin
for 7 min and stained with 6% Giemsa stain solution for 3.5
min. The number of chromosomes was analyzed in 40–50
cells from the third and the fifth passages of each HCEC
preparation. A detailed karyotype was analyzed in 10–16 cells
from  the  third  and  the  fifth  passages  of  each  HCEC
preparation. The standard International System for Human
Cytogenetic  Nomenclature  (ISCN),  1995,  and  definitions
were followed.
Statistics:  The  frequency  of  loss  or  gain  of  individual
chromosomes was examined. The frequency of aneuploidy
per case (the number of abnormal cells divided by the total
number  of  cells  examined  at  metaphase)  was  tested  for
correlation  with  age  by  Spearman’s  correlation  analysis.
Stepwise  multiple  regression  analysis  was  performed  to
investigate the relationship between two variables (donor age
and  presence  of  cryopreservation)  and  the  frequency  of
aneuploidy. We considered p values <0.05 as statistically
significant.
TABLE 2. DISTRIBUTION OF TOTAL CHROMOSOME NUMBER AND THE FREQUENCY OF ANEUPLOIDY IN CULTURED HUMAN CORNEAL ENDOTHELIAL
CELLS AT THE THIRD PASSAGE.
1 3 - 0000 50 0 0
2 12 - 0000 50 0 0
3 21 - 0000 49 1 2
4 38 + (28 months) 0000 43 6 12.2
5 55 + (26 months) 000 42 6 2 88
6 60 - 0003 45 2 10
7 61 + (25 months) 000 43 7 0 86
8 73 - 0007 18 25 64
9 18 + (23 months) 0000 50 0 0
10 57 - 000 50 0 0 100
11 70 - 0031 43 3 14
12 77 + (13 months) 0000 50 0 0
Each subcolumn within the “Number of chromosomes” column shows the number of cells found to be containing the specific
number of chromosomes corresponding to the subcolumn heading. This table has been arranged according to donor age in 2
subgroups as follows: #1~8: The examination was conducted at both passages 3 and 5. #9~12: The examination was conducted
at passage 3 only.
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Donor #         Age Cryopreservation
Number of chromosomes
Frequency of
  aneuploidy
        (%) 42          43         44         45         46           47Figure  2.  Examples  of  karyotypes  of
cultured  human  corneal  endothelial
cells.  A:Normal  karyotype  (46,  XX)
was observed in passage 5 of 60-year-
old donor (#6). B: Sex chromosome Y
deficiency (45, X, –Y) was observed in
passage 5 of 61-year-old donor (#7). A
circle  shows  the  deficiency  of  sex
chromosome  Y.  C:  Chromosome  8
trisomy (47, XX, +8) was observed in
passage 3 of 38-year-old donor (#4). A
circle shows chromosome 8 trisomy.
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945RESULTS
Figure 1 shows the examples of HCECs of young and old
donors at primary culture and fifth passage. HCECs could be
cultured to be confluent, and hexagonal confluent cells were
recognized at both primary and fifth passages. Figure 2 shows
representative examples of cultured HCEC karyotypes.
Table 2 shows the distribution of the total chromosome
number and aneuploidy frequency of cultured HCECs at the
third passage, and Table 3 shows the distribution at the fifth
passage.  The  frequency  of  aneuploidy  is  expressed  as  a
percentage. All examined cells showed the normal number of
chromosomes in 4 out of 12 cases at the third passage and in
2 out of 16 cases at the fifth passage.
Table 4 and Table 5 present detailed karyotyping of the
third and fifth passages, respectively. At the third passage, five
cases  (#1,  2,  3,  9,  12)  showed  almost  normal  karyotypes
whereas five cases (#5, 6, 7, 10, 11) showed sex chromosome
loss. One case (#8) showed chromosome 21 trisomy. At the
fifth passage, five cases (#1, 2, 3, 6, 14) showed almost normal
karyotypes  while  four  cases  (#5,  7,  18,  19)  showed  sex
chromosome  loss.  Three  cases  (#15,  16,  20)  showed
chromosome  8  trisomy,  and  one  case  (#8)  showed
chromosome 21 trisomy. In eight cases (#1–8), karyotyping
was examined at both the third and fifth passages. When the
changes in karyotyping from the third to fifth passages were
analyzed in these cases, a normal karyotype was maintained
in three cases (#2, 3, 6) and the same abnormal karyotype was
maintained in four cases (#4, 5, 7, 8). In case #1, the frequency
of abnormal karyotype (45, X, -X) increased from the third
passage to the fifth passage.
Figure  3  and  Figure  4  present  the  histograms  of  the
distribution of chromosome aneuploidy that was observed in
cultured HCECs at the third and fifth passages. At the third
passage, 25% of the cases gained chromosome 8 and 33.3%
of the cases lost chromosome Y. At the fifth passage, 31.3%
of the cases gained chromosome 8 and 25% of the cases lost
chromosome Y.
Figure 3. Distribution of chromosome aneuploidy in cultured human
corneal endothelial cells at third passage. The frequency of gain or
loss of each chromosome is shown.
TABLE 3. DISTRIBUTION OF TOTAL CHROMOSOME NUMBER AND THE FREQUENCY OF ANEUPLOIDY IN CULTURED HUMAN CORNEAL ENDOTHELIAL
CELLS AT THE FIFTH PASSAGE.
Donor #         Age Cryopreservation
Number of chromosomes
Frequency of
  aneuploidy
        (%) 42          43           44           45             46            47
1 3 - 0 002 48 0 4
2 12 - 0 000 50 0 0
3 21 - 0 010 49 0 2
4 38 + (28 months) 0 000 41 9 18
5 55 + (26 months) 0 0 0 48 0 2 100
6 60 - 0 000 50 0 0
7 61 + (25 months) 0 0 0 50 0 0 100
8 73 - 0 010 5 44 90
13 2 + (period n.a.) 0 016 25 9 39
14 4 + (period n.a.) 0 112 40 1 11.1
15 20 + (period n.a.) 0 001 45 4 10
16 45 + (4 months) 1 110 6 41 88
17 57 + (16 months) 0 012 46 1 8
18 58 + (1 month) 0 1 2 29 18 0 64
19 68 + (17 months) 0 1 1 48 0 0 100
20 75 + (19 months) 0 001 14 35 72
Each subcolumn within the “Number of chromosomes” column shows the number of cells found to be containing the specific
number of chromosomes corresponding to the subcolumn heading. This table has been arranged according to donor age in 2
subgroups as follows: #1~8: The examination was conducted at both passages 3 and 5. #13~20: The examination was conducted
at passage 5 only.
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946Figure 5 and Figure 6 show the relation between donor
age and the frequency of aneuploidy at the third and fifth
Figure 4. Distribution of chromosome aneuploidy in cultured human
corneal endothelial cells at fifth passage. The frequency of gain or
loss of each chromosome is shown.
passages,  respectively.  Donor  age  and  the  frequency  of
aneuploidy had no significant correlation at the third passage
(R=0.437,  p=0.147)  but  had  a  statistically  significant
correlation  at  the  fifth  passage  (R=0.653,  p=0.042).  The
regression  curve  in  the  fifth  passage  is  expressed  by  the
equation: (frequency of aneuploidy) = 2.08+1.032 x (age).
Stepwise multiple regression analysis revealed that age was
the  only  explanatory  variable  that  was  relevant  to  the
frequency  of  aneuploidy  (R=0.660,  p=0.0029).  The  other
variable, cryopreservation, was irrelevant to the frequency of
aneuploidy.
DISCUSSION
In  the  current  study,  cultured  HCECs  demonstrated
aneuploidy at the third and fifth passages in most cases. Has
TABLE 4. KARYOTYPING OF HUMAN CORNEAL ENDOTHELIAL CELLS AT THE THIRD PASSAGE.
Donor # Karyotyping
1 46,XX,t(12;18)(q13;121)=1,46XX=10
2 46,XY=10
3 46XX,?inv(2)(p11q12),t(6;11)(q23;p13)=1,47,XX,+3=1, 46,XX=10
4 47,XX+3=2, 48,idem,+21=1, 47,XX,+X=1, 47,XX,+8=1, 47,XX,+12=1, 47,XX,+21=1, 46,XX=9
5 45,X,-Y=10, 47,idem,+7,+8=2, 46,idem,+X=1, 46,idem,+8=1, 46,XY=2
6 45,X,-X=3,47,XX,+20=1,47,XX,+21=1,46,XX=10
7 45,X,–Y=7, 46,idem,+8=3
8 47,XX,+21=5, 45,X,-X=2,46,XX=3
9 46,XY=10
10 45,X,-Y=10
11 45,X,-Y=7, 43,X,-Y,-21,-22=1 45,X,-Y,-11,+20=1 46,X,-Y,-14,+16,+20=1
12 46,XY=10
Specific karyotypes found in each donor and cell number in which each specific karyotype was found are shown.
TABLE 5. KARYOTYPING OF HUMAN CORNEAL ENDOTHELIAL CELLS AT THE FIFTH PASSAGE.
Donor # Karyotyping
1 45,X,-X=2,46,XX,t(2;17)(p10;q10)=1,46XX=10
2 46,XY=10
3 44,XX,-19,-22=1, 46,XX=10
4 47,XX,+X=4, 47,XX,+3=2, 46, XX=10
5 45,X,-Y=10, 47,idem,+7,+8=1, 47,XY,+20=1
6 46XX=10
7 45,X,-Y=10
8 47,XX,+21=10 46,XX=1
13 45,X,-Y=2, 45,idem,t(1;14)(p34;p13)=1,47,XY,+18=3,46,XY=6
14 46XX=10
15 47,XX,+8=4,46,XX=10
16 47,XX,+8=10,46,XX,=3
17 46,X,-X,+8=5,47,XX,+4=1,46,XX=4
18 45,X,-Y=4 46,idem,+3=1 46XY=5
19 45,X,-X=10
20 47,XX,+8=10
Specific karyotypes found in each donor and cell number in which each specific karyotype was found are shown.
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947the aneuploidy observed in cultured HCECs been present in
vivo or has it been induced during culture? Aneuploidy is
induced during cell division, and HCECs hardly show cell
division in vivo. Thus, the aneuploidy observed in cultured
HCECs may have been induced during culture. However,
because cells need to go into the cell division cycle when we
examine  the  karyotype  using  our  method,  we  could  not
investigate  the  karyotype  before  culture.  Changes  in
karyotype from the third to fifth passage were examined in
eight cases. The same karyotype was maintained in seven of
those cases, and a new abnormal karyotype appeared in only
one  of  them.  Taken  together,  most  abnormal  karyotypes
observed in cultured HCECs may have been induced at a very
early stage during culture.
Donor  age  and  the  frequency  of  aneuploidy  had  a
significantly positive correlation at the fifth passage. This
result  suggests  that  chromosome  damage  accumulates  in
HCECs in vivo with increasing age and that aneuploidy is
induced  in  HCECs  when  they  are  forced  to  undergo  cell
division in vitro. Previous studies reported that the telomere
is not shortened in HCECs of elderly persons probably due to
the very low proliferative activity of HCECs in vivo [16,17].
Thus, the shortening of telomeres is not a cumulative change
in HCECs with increasing age. Further studies are necessary
to elucidate the specific mechanisms of accumulating damage
in HCEC chromosomes with increasing age.
In  our  study,  cultured  HCECs  tended  to  have  a
chromosome  mosaic  of  sex  chromosome  monosomy  and
chromosome 8 trisomy. Previous studies reported that the X
chromosome in females and the Y chromosome in males
showed  age-dependent  loss  in  peripheral  lymphocytes
[18-21],  bone  marrow  cells  [21],  and  corneal  keratocytes
Figure 5. Relationship between donor age and the frequency of
aneuploidy in cultured human corneal endothelial cells at the third
passage.  Donor  age  and  the  frequency  of  aneuploidy  had  no
significant correlation (R=0.437, p=0.147).
[22,23]. Thus, loss of sex chromosomes is most frequently
observed  as  an  age-dependent  chromosome  abnormality
regardless of cellular type. The results in this study confirmed
that the loss of a sex chromosome tends to occur in HCECs
with increasing age as in other types of cells. On the other
hand,  chromosome  8  trisomy  was  the  most  frequently
observed  trisomy  in  acute  myeloid  leukemia  [24],  and
chromosome 8 trisomy mosaic syndrome is associated with
corneal opacity [25]. In addition, chromosome 8 includes
oncogenes c-myc and c-mos. Further study is necessary to
elucidate  the  association  between  this  information  on
chromosome 8 and the frequent occurrence of chromosome 8
trisomy in cultured HCECs.
Stepwise multiple regression analysis revealed that age
but not cryopreservation was the explanatory variable relevant
to  the  frequency  of  aneuploidy,  suggesting  that
cryopreservation  is  irrelevant  to  aneuploidy.  However,
because the number of subjects without cryopreservation in
this study was small, a further study with a larger number of
cases with or without cryopreservation is needed to confirm
the relationship between cryopreservation and aneuploidy.
Our previous study demonstrated that the average area of
HCECs at the fourth passage as well as the percentage of cells
larger than 2000 μm2 increased in a manner proportional to
donor age [7]. Senoo et al. [26] reported that HCECs from old
donors can proliferate but respond more slowly and to a lesser
extent than cells from young donors. Moreover, HCECs from
the central corneal area have a relatively lower replicative
competence in older donors than in young donors [27]. These
Figure 6. Relationship between donor age and the frequency of
aneuploidy in cultured human corneal endothelial cells at the fifth
passage.  Donor  age  and  the  frequency  of  aneuploidy  had  a
statistically significant correlation (R=0.653, p=0.042). The equation
of the regression curve is:
                 (frequency of aneuploidy) = 2.08+1.032 x (age).
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948age-related reductions in relative proliferative capacity and
the senescence characteristics previously observed in cultured
HCECs may be related to the chromosomal abnormalities
observed in this study.
Because  karyotype  changes  are  often  associated  with
carcinogenesis, the existence of chromosomal abnormalities
in HCECs is clearly a concern for clinical use. The results in
this  study  demonstrated  that  donor  age  and  frequency  of
aneuploidy have a significantly positive correlation at the fifth
passage.  Therefore,  our  results  indicate  that  HCECs  for
clinical therapies should be obtained from donors as young as
possible.  Moreover,  careful  examination  of  karyotype  in
cultured HCECs is crucial before clinical application.
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